gilead cvs - Search News

News

CVS, HIV and Gilead

Exclusive: CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness.

· 1d

Gilead stock falls after CVS holds off adding HIV prevention shot to plans

Fierce Healthcare · 1d

For now, CVS declines to cover Gilead's long-acting HIV PrEP treatment Yeztugo

STAT1d

Pharmalittle: We’re reading about Gilead’s HIV drug, FDA speeding review of a rare disease drug, and more

CVS Health will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, despite the medicine's ...

Benzinga.com1y

Invest $50K in CVS Health and Gilead Sciences to Become a ... - Benzinga

CVS’s expansion into primary care is expected to drive long-term growth, while Gilead’s strong pipeline and market position in virology and oncology support its continued dividend growth.

St. Louis Post-Dispatch10y

CVS will cover Gilead hepatitis C treatment over new AbbVie drug

CVS Health Corp., one of the largest U.S. managers of drug benefits, said it would give preferred status to the hepatitis C treatments from Gilead Sciences and cover a new competing treatment from ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results